StonvexLoading…
StonvexStonvexStonvexCore line items from IOSP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.78B | $1.85B | $1.95B | $1.96B |
Operating Income | $129.50M | $177.90M | $161.60M | $187.30M |
Net Income | $116.60M | $35.60M | $139.10M | $133.00M |
EPS (Diluted) | $4.67 | $1.42 | $5.56 | $5.32 |
Total Assets | $1.83B | $1.73B | $1.71B | $1.60B |
Total Liabilities | $499.50M | $518.60M | $557.80M | $563.30M |
Cash & Equivalents | $292.50M | $289.20M | $203.70M | $147.10M |
Free Cash Flow OCF − CapEx | $88.00M | $143.10M | $145.20M | $42.10M |
Shares Outstanding | 24.99M | 25.12M | 25.02M | 24.98M |